FDA Inspection 1065569 — Kings Park Slope Inc

Kings Park Slope Inc — FEI 3007174596

The FDA completed an inspection of Kings Park Slope Inc on September 14, 2018 in Brooklyn, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brooklyn, NY (United States)

Citations

IDCFRDescription
18961FDCA 501(a)(2)(A)Air flow quality, higher classified area
18970FDCA 501(a)(2)(A)Disinfecting and cleaning agents, ISO 5 area
18972FDCA 501(a)(2)(A)Inadequate sporicidal agents, cleanroom and ISO 5 area